Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata

Journal of Neuroscience

Volumn 24, Issue 40, 2004, Pages 8704-8710

  Threlfell, Sarah ^a   Cragg, Stephanie J ^a   Kalló, Imre ^b,c   Turi, Gergely F ^c   Coen, Clive W ^b   Greenfield, Susan A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

5 hydroxytryptamine; Basal ganglia; Fast scan cyclic voltammetry; Histamine; Parkinson's disease; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ALPHA METHYLHISTAMINE; CARBON FIBER; GLUTAMATE RECEPTOR ANTAGONIST; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 3 ANTAGONIST; SODIUM CHANNEL BLOCKING AGENT; THIOPERAMIDE; HISTAMINE AGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DENDRITE; DOPAMINE RELEASE; DRUG POTENCY; HISTAMINE RELEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHIBITION KINETICS; MALE; MICROELECTRODE; MOTOR CONTROL; NERVE FIBER; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONIN RELEASE; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS RETICULATA; ACTION POTENTIAL; ANIMAL; CELL CULTURE; CYTOLOGY; ELECTROSTIMULATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; ELECTRIC STIMULATION; HISTAMINE; HISTAMINE AGONISTS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3; SEROTONIN; SODIUM CHANNEL BLOCKERS; SUBSTANTIA NIGRA;

EID: 5444270675     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2690-04.2004     Document Type: Article

References (55)

1. Adams JC (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457-1463.
2. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271.
3. Anichtchik OV, Rinne JO, Kalimo H, Panula P (2000a) An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 163:20-30.
4. Anichtchik OV, Huotari M, Peitsaro N, Haycock JW, Mannisto PT, Panula P (2000b) Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12:3823-3832.
5. Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P (2001) Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8:707-716.
6. Arias-Montano JA, Floran B, Garcia M, Aceves J, Young JM (2001) Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices. Br J Pharmacol 133:165-171.
7. Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832-837.
8. Arrang JM, Drutel G, Schwartz JC (1995) Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex. Br J Pharmacol 114:1518-1522.
9. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
10. Boschert U, Amara DA, Segu L, Hen R (1994) The mouse 5- hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182.
11. Brown RE, Haas HL (1999) On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus. J Physiol (Lond) 515:777-786.
12. Brown RE, Reymann KG (1996) Histamine H3 receptor-mediated depression of synaptic transmission in the dentate gyrus of the rat in vitro. J Physiol (Lond) 496:175-184.
13. Bunin MA, Prioleau C, Mailman RB, Wightman RM (1998) Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. J Neurochem 70:1077-1087.
14. Corvaja N, Doucet G, Bolam JP (1993) Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 55:417-427.
15. Cragg S, Rice ME, Greenfield SA (1997a) Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J Neurophysiol 77:863-873.
16. Cragg SJ, Hawkey CR, Greenfield SA (1997b) Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences. J Neurochem 69:2378-2386.
17. Cragg SJ, Hille CJ, Greenfield SA (2002) Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J Neurosci 22:5705-5712.
18. Davidson C, Stamford JA (1996) Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5- HT1B and 5-HT1D autoreceptors. Neuropharmacology 35:1627-1634.
19. Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y (1995) Levodopa-induced dyskinesias are improved by fluoxetine. Neurology 45:1855-1858.
20. Fink K, Schlicker E, Neise A, Gothert M (1990) Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 342:513-519.
21. Fox SH, Brotchie JM (2000) 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease. Mov Disord 15:1064-1069.
22. Garcia M, Floran B, Arias-Montano JA, Young JM, Aceves J (1997) Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 80:241-249.
23. Garcia-Ramirez M, Aceves J, Arias-Montano J-A (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav Brain Res 154:409-415.
24. Giorgetti M, Bacciottini L, Bianchi L, Giovannini MG, Cecchi M, Blandina P (1997) GABAergic mechanism in histamine H3 receptor inhibition of K(+)-evoked release of acetylcholine from rat cortex in vivo. Inflamm Res 46 [Suppl 1]:S33-S34.
25. Hew RW, Hodgkinson CR, Hill SJ (1990) Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands. Br J Pharmacol 101:621-624.
26. Hopwood SE, Stamford JA (2001) Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei. Neuropharmacology 40:508-519.
27. Iravani MM, Kruk ZL (1997) Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25:93-102.
28. Jacobs BL, Fornal CA (1993) 5-HT and motor control: a hypothesis. Trends Neurosci 16:346-352.
29. Kalló I, Butler JA, Barkovics-Kallo M, Goubillon ML, Coen CW (2001) Oestrogen receptor beta-immunoreactivity in gonadotropin releasing hormone-expressing neurones: regulation by oestrogen. J Neuroendocrinol 13:741-748.
30. Liposits Z, Sherman D, Phelix C, Paull WK (1986) A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry 85:95-106.
31. Molina-Hernandez A, Nunez A, Sierra JJ, Arias-Montano JA (2001) Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 41:928-934.
32. Moukhles H, Bosler O, Bolam JP, Vallee A, Umbriaco D, Geffard M, Doucet G (1997) Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76:1159-1171.
33. Nicholson SL, Brotchie JM (2002) 5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease-opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur J Neurol 9 [Suppl 3]:1-6.
34. Nissbrandt H, Waters N, Hjorth S (1992) The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch Pharmacol 346:12-19.
35. O'Connor JJ, Kruk ZL (1991) Frequency dependence of 5-HT autoreceptor function in rat dorsal raphe and suprachiasmatic nuclei studied using fast cyclic voltammetry. Brain Res 568:123-130.
36. Panula P, Yang HY, Costa E (1984) Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572-2576.
37. Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989) Histamine- immunoreactive nerve fibers in the rat brain. Neuroscience 28:585-610.
38. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Sydney: Academic.
39. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM (2002) A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114:173-193.
40. Prast H, Tran MH, Fischer H, Kraus M, Lamberti C, Grass K, Philippu A (1999) Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 360:558-564.
41. Prell GD, Hough LB, Khandelwal J, Green JP (1996) Lack of a precursor-product relationship between histamine and its metabolites in brain after histidine loading. J Neurochem 67:1938-1944.
42. Rice ME, Nicholson C (1989) Measurement of nanomolar dopamine diffusion using low-noise perfluorinated ionomer coated carbon fiber micro-electrodes and high-speed cyclic voltammetry. Anal Chem 77:1805-1810.
43. Rick CE, Stanford IM, Lacey MG (1995) Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience 69:903-913.
44. Ryu JH, Yanai K, Watanabe T (1994) Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study. Neurosci Lett 178:19-22.
45. Sari Y, Miquel MC, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M, Verge D (1999) Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899-915.
46. Schlicker E, Betz R, Gothert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 337:588-590.
47. Schlicker E, Fink K, Hinterthaner M, Gothert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol 340:633-638.
48. Schlicker E, Behling A, Lummen G, Gothert M (1992) Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn Schmiedebergs Arch Pharmacol 345:489-493.
49. Schlicker E, Fink K, Detzner M, Gothert M (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect 93:1-10.
50. Schlicker E, Werthwein S, Zentner J (1999) Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain. Fundam Clin Pharmacol 13:120-122.
51. Schwartz JC, Lampart C, Rose C (1972) Histamine formation in rat brain in vivo: effects of histidine loads. J Neurochem 19:801-810.
52. Stamford JA, Davidson C, McLaughlin DP, Hopwood SE (2000) Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality? Trends Neurosci 23:459-465.
53. Venton BJ, Michael DJ, Wightman RM (2003) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J Neurochem 84:373-381.
54. Vizuete ML, Traiffort E, Bouthenet ML, Ruat M, Souil E, Tardivel-Lacombe J, Schwartz JC (1997) Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience 80:321-343.
55. Yamamoto Y, Mochizuki T, Okakura-Mochizuki K, Uno A, Yamatodani A (1997) Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus. Methods Find Exp Clin Pharmacol 19:289-298.